Skip to content
Research Article Open access CC BY 4.0

Estimate the Spectrum and Prescription Pattern in Patients with Myocardial Infarction, Angina, Congestive Cardiac Failure at a Tertiary Care Hospital- Retrospective Study

K. V. Ramanath, Niloufar Emami, Alireza Lashani

International Journal of Biochemistry Research & Review · pp. 1–11 · Published 15 Apr 2022

10.9734/ijbcrr/2022/v31i330306

Abstract

Introduction: Analysis of the prescription patterns is essential to improve rational prescribing in cardiac patients to decrease the risk associated with cardiovascular drugs & also to reduce morbidity and mortality. However, this type of study is progressively more important because of a boost in marketing of new medicines, variations in the prescribing and consumption of drugs, growing concern about delayed adverse effects, cost of drugs, and volume of prescription provokes us to carry out this study.  Objectives: To evaluate cardiovascular disease (Myocardial Infarction (MI), ANGINA, and Congestive Cardiac Failure (CCF) drugs prescribing pattern & its cost. Methods: This study is a Retrospective case study carried out for a period of 6months at Sagar Hospitals, Bangalore, by collecting the required data in a structured questionnaire. Results: Out of 250 patient cases observed, patients aged 60-69 were 31.6%, followed by 50-59 (26.8%) are more prone to CAD & males were more when compared to females. The study showed the highest number of patients suffering from Angina and the second highest in MI, and few patients have been diagnosed with CCF. Conclusion: This study showed that Coronary artery disease was managed by antiplatelets, antihypertensives, statins, and diuretics; Angina has the highest diagnosis rate under this study. However, the antianginal drug class does not practice well. However, these studies also show the path for the pharmacist's role in promoting rational drug promotion in cardiac disease management.

CAD: Coronary artery disease ACS: Acute coronary syndrome MI: Myocardial infarction HF: Heart failure IHD: Ischemic Heart disease CA: Cost Analysis Prescription pattern

References (10)

  1. 1 Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients [DOI]
  2. 2 HEART DISEASE AND STROKE STATISTICS–2014 UPDATE: A REPORT FROM THE AMERICAN HEART ASSOCIATION [DOI]
  3. 3 Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) [DOI]
  4. 4 Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data [DOI]
  5. 5 The changing patterns of cardiovascular diseases and their risk factors in the states of India: the Global Burden of Disease Study 1990–2016 [DOI]
  6. 6 2013 ESC guidelines on the management of stable coronary artery disease. The Task Force on the management of stable coronary artery disease of the European Society of Cardiology [DOI]
  7. 7 Two-year outcomes in patients admitted with non-ST elevation acute coronary syndrome: results of the OASIS registry 1 and 2.
  8. 8 Drug Utilization Pattern in Cardiovascular Diseases: A Descriptive Study in Tertiary Care Settings in Pakistan [DOI]
  9. 9 Medical management of chronic stable angina [DOI]
  10. 10 Myocardial infarction: management of the subacute period.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

46

Page views

0

PDF downloads

8

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.